Comparison between Concord Biotech IPO and India Shelter Finance IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while India Shelter Finance IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the India Shelter Finance IPO is up to ₹1,200.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of India Shelter Finance IPO is ₹493.00 per share.
| Concord Biotech IPO | India Shelter Finance IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹5 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹469.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹493.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹493.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | |
| Market Lot Size | 20 shares | 30 shares |
| Fresh Issue Size | 0 shares | 1,62,27,180 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹800.00 Cr |
| OFS Issue Size | 2,09,25,652 shares | 81,13,588 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹400.00 Cr |
| Issue Size Total | 2,09,25,652 shares | 2,43,40,768 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹1,200.00 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while India Shelter Finance IPO opens on Dec 13, 2023. The closing date of Concord Biotech IPO and India Shelter Finance IPO is Aug 08, 2023, and Dec 15, 2023, respectively.
| Concord Biotech IPO | India Shelter Finance IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Dec 12, 2023 |
| Issue Open | Aug 04, 2023 | Dec 13, 2023 |
| Issue Close | Aug 08, 2023 | Dec 15, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Dec 18, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Dec 19, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Dec 19, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Dec 20, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Jan 17, 2024 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Mar 17, 2024 |
Concord Biotech IPO P/E ratio is 32.29, as compared to India Shelter Finance IPO P/E ratio of 28.22.
| Concord Biotech IPO | India Shelter Finance IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 56.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 48.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 28.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹5277.62 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 13.4% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹17.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 13.4% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in India Shelter Finance IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 48,68,154 shares in India Shelter Finance IPO.
| Concord Biotech IPO | India Shelter Finance IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 73,02,229 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 48,68,154 shares |
| NII | 31,37,348 shares | 36,51,116 shares |
| RII | 73,20,479 shares | 85,19,269 shares |
| Employee | 10,000 shares | |
| Others | ||
| Total | 2,09,25,652 shares | 2,43,40,768 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas India Shelter Finance IPO subscribed 38.59x.
| Concord Biotech IPO | India Shelter Finance IPO | |
|---|---|---|
| QIB (times) | 67.67x | 94.29x |
| NII (times) | 16.99x | 29.97x |
| Big NII (times) | 19.30x | 29.77x |
| Small NII (times) | 12.37x | 30.37x |
| RII (times) | 3.78x | 10.46x |
| Employee (times) | 24.48x | |
| Other (times) | ||
| Total (times) | 24.87x | 38.59x |
